Skip to main content

Advertisement

Table 4 Anatomic and Snellen visual acuity outcomes 6 months prior to IAI switch, at time of IAI switch, and 6 months after IAI switch

From: Effect of intravitreal aflibercept on recalcitrant diabetic macular edema

# 6 months prior to IVE switch Time of IVE switch 6 months after IVE switch
CRT(μ) Change in CRT (%) Snellen visual acuity CRT (μ) Snellen visual acuity CRT (μ) Charge in CRT (%) Snellen visual acuity
1 299 +9.7 20/40 398 20/50 284 −23.1 20/40
2 490 +1.0 20/50 574 20/200 267 −44.3 20/70
3 496 −10.0 20/30 463 20/40 417 −5.7 20/25
4 313 +98.1 20/25 580 20/200 454 −34.4 20/200
5 460 +6.5 20/70 459 20/50 285 −34.5 20/50
6 384 +2.2 20/80 363 20/40 341 −5.7 20/40
7 383 +24.2 20/100 469 20/100 263 −40.0 20/50
8 690 +18.6 20/50 685 20/200 423 −13.2 20/200
9 353 +13.7 20/70 496 20/100 262 −41.9 20/70
10 347 +50.5 20/25 444 20/40 283 −36.4 20/25
11 498 −9.8 20/50 428 20/70 312 −18.6 20/40
  Mean = 428 Mean = +18.6%   Mean = 487   Mean = 326 Mean = −27.1%